PDF herunterladen
Zeitschrift für Orthomolekulare Medizin 2014; 12(2): 20-25
DOI: 10.1055/s-0034-1368498
Praxistipps
Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Mikronährstoffe in der hausärztlichen Betreuung älterer Patienten

Stephan Wey
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
25. Juni 2014 (online)

  Lizenzen und Reprints

Zusammenfassung

Ältere Menschen sind aufgrund von Fehlernährung, Resorptionsstörungen, Erkrankungen und Medikamenteneinnahme gefährdet für Mikronährstoffmängel. Entsprechende Diagnostik und Supplementierung orthomolekularer Substanzen erscheint zur Prophylaxe chronischer und neurodegenerativer Erkrankungen sowie von Osteoporose, Sturzneigung und Infekten notwendig für ein „rüstiges“ Altern mit hoher Lebensqualität.

Schlüsselwörter

Geriatrie - Mikronährstoffmangel - orthomolekulare Therapie - Demenz - Morbus Parkinson
 

  • Literatur

  • 1 Annweiler C, Fantino B, Schott AM et al. Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol 2012; 19: 1023-1029
    CrossrefSuche in Google Scholar
  • 2 Burgaz A, Orsini N, Larsson SC, Wolk A. Blood-25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29: 636-645
    CrossrefSuche in Google Scholar
  • 3 Ginde AA, Mansbach JM, Camargo CA. Association between serum-25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169: 384-390
    CrossrefSuche in Google Scholar
  • 4 Girodon F, Galan P, Monget AL et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients. Min. Vit. Aox. geriatric network. Arch Int Med 1999; 159: 748-754
    CrossrefSuche in Google Scholar
  • 5 Gröber U. Neuroenhancement mit α-Liponsäure. ZKM 2012; 1: 45-49
    Suche in Google Scholar
  • 6 Jazayeri S, Tehrani-Doost M, Keshavarz SA et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Austr New Zeal J Psychiatry 2008; 42: 192-198
    Suche in Google Scholar
  • 7 Jesse S, Ludolph AC. Die Vitamine B1, B6 und B12 . Der Nervenarzt 2012; 83: 521-534
    CrossrefSuche in Google Scholar
  • 8 Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012; 66: 411-418
    CrossrefSuche in Google Scholar
  • 9 Lappe JM, Travers-Gustafson D, Davies KM et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591
    Suche in Google Scholar
  • 10 Llewellyn DJ, Langa K, Lang I. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009; 22: 188-195
    CrossrefSuche in Google Scholar
  • 11 Maczureck A, Hager K, Kenklies M et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimerʼs disease. Adv Drug Deliv Rev 2008; 60: 1463-1470
    CrossrefSuche in Google Scholar
  • 12 Nourhashemi F, Gillette-Guyonnet S, Andrieu S. Alzheimer disease: protective factors. Am J Clin Nutr 2000; 71: 643S-649S
    Suche in Google Scholar
  • 13 Parkera J, Hashmia O, Dutton D. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. J Maturitas 2009; 65: 225-236
    Suche in Google Scholar
  • 14 Rajabally YA, Martey J. Neuropathy in Parkinson disease: prevalence and determinants. Neurology 2011; 77: 1947-1950
    CrossrefSuche in Google Scholar
  • 15 Schaefer EJ, Bongard V, Beiser AS et al. Plasma phosphatidylcholine docoshexaenoic acid content and risk of dementia and Alzheimer disease: the Framingahm Heart Study. Arch Neurol 2006; 63: 1545-1550
    CrossrefSuche in Google Scholar
  • 16 Schilling S. Epidemic vitamin D deficiency among patients in an elderly care rehabilitation facility. Dtsch Arztebl Int 2012; 109: 33-38
    Suche in Google Scholar
  • 17 Shults CW, Oakes D, Kieburtz K. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002; 59: 1541-1550
    CrossrefSuche in Google Scholar
  • 18 Turner MK, Hooten WM, Schmidt JE et al. . Pain Med 2008; 9: 979-984
    CrossrefSuche in Google Scholar
  • 19 Van Dam F, Van Gool WA. Hyperhomocysteinemia and Alzheimerʼs disease: A systematic review. Arch Gerontol Geriatr 2009; 48: 425-430
    CrossrefSuche in Google Scholar
  • 20 Evatt ML, DeLong MR, Khazai N et al. Prevalence of Vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008; 65: 1348-1352
    CrossrefPubMedSuche in Google Scholar
  • 21 Ding H, Dhima K, Lockhart KC et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease. Neurology 2013; 81: 1531-1537
    CrossrefSuche in Google Scholar
  • 22 Mischley L, Allen J, Bradley R. Coenzyme Q 10 deficiency in patients with Parkinsonsʼs disease. J Neurol Sci 2012; 318: 72-75
    CrossrefSuche in Google Scholar
  • 23 von Schacky C. Hirnstruktur und Hirnfunktion: Die Rolle der Omega-3-Fettsäuren. Zs f Orthomol Med 2014; 1: 20-23
    Thieme ConnectSuche in Google Scholar